Categories: News

Job Research Foundation Announces 4th Round of Funding: $400,000 in Grants Available to Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder

NEW YORK, May 18, 2021 /PRNewswire/ — The Job Research Foundation, which seeks to help find a cure for Job Syndrome by providing the global scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, has announced the fourth round of grant funding. The Foundation will award two two-year grants in the amount of $200,000 each. The grants will be awarded to scientific researchers who are investigating the causes of, and treatments for, Job Syndrome. Grant applications can be found online at www.jobresearchfoundation.org. Deadline to apply is October 15, 2021.

The long-term goal of the Foundation is to help advance research to find a cure for Job Syndrome. In the short term, the Foundation hopes the research will improve the treatments for patients suffering from the rare disorder.

To date the organization has funded a total of ten research projects across the world. In 2019, Job Research Foundation awarded four grants in the first round of funding to researchers from Australia, Spain, Germany, and the United States. In 2020, four grants were awarded to researchers in the United States and the United Kingdom in the second round of funding. This year’s recipients are based in the United States and in Germany.

Special consideration will be given to research focused on Job Syndrome and Pulmonary Function. Previous applicants can apply in subsequent years to extend their research. The application process is open to researchers world-wide and awardees will be announced between December 2021 and January 2022.

The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments to help those suffering with Job Syndrome. Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. Visit https://www.jobresearchfoundation.org/ for additional details.

MEDIA CONTACT:  Risa B. Hoag, GMGPR, 845-627-3000, 309938@email4pr.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/job-research-foundation-announces-4th-round-of-funding-400-000-in-grants-available-to-researchers-investigating-causestreatments-of-rare-multisystem-immunodeficiency-disorder-301293587.html

SOURCE Job Research Foundation

Staff

Recent Posts

QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology

SINGAPORE, Nov. 26, 2024 /PRNewswire/ -- QDX proudly announces that the team led by its…

36 minutes ago

Hisense Launches End-of-Year Sale Across the GCC Featuring Exclusive Surprises

DUBAI, UAE, Nov. 26, 2024 /PRNewswire/ -- Hisense, a global leader in consumer electronics and…

36 minutes ago

Gold Biotechnology Enhances Visibility and Engagement Through Bioz Partnership

PALO ALTO, CA / ACCESSWIRE / November 26, 2024 / Bioz, Inc., an innovator of…

36 minutes ago

KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical…

13 hours ago

Metro Inc. Prices Aggregate C$500 Million Senior Unsecured Notes Offering

/NOT FOR DISSEMINATION IN THE UNITED STATES/ MONTRÉAL, Nov. 25, 2024 /CNW/ - METRO INC. ("Metro")…

13 hours ago